These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Decision aids help patients but still are not widely used. Sinha G J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006197 [No Abstract] [Full Text] [Related]
24. Integrative dermatology for psoriasis: facts and controversies. Treloar V Clin Dermatol; 2010; 28(1):93-9. PubMed ID: 20082958 [TBL] [Abstract][Full Text] [Related]
25. [Are « complementary » cancer therapies actually indirectly harmful?]. Jordan B Med Sci (Paris); 2018 Nov; 34(11):999-1002. PubMed ID: 30526822 [TBL] [Abstract][Full Text] [Related]
26. Communication in cancer care: discussing complementary and alternative medicine. Frenkel M; Ben-Arye E; Cohen L Integr Cancer Ther; 2010 Jun; 9(2):177-85. PubMed ID: 20356950 [TBL] [Abstract][Full Text] [Related]
27. Improving Care through Better Communication: Understanding the Benefits. Damm L; Leiss U; Habeler U; Ehrich J J Pediatr; 2015 May; 166(5):1327-8. PubMed ID: 25919744 [No Abstract] [Full Text] [Related]
28. 'It couldn't hurt .... Could it?' Safety of complementary and alternative medicine practices. Kruskal B Acta Paediatr; 2009 Apr; 98(4):628-30. PubMed ID: 19290964 [No Abstract] [Full Text] [Related]
29. New developments in the realm of complementary medicine. J Support Oncol; 2005; 3(3):238-40, 245-6. PubMed ID: 15915827 [No Abstract] [Full Text] [Related]
31. Information and consent. Gillett GR N Z Med J; 1988 Nov; 101(858):792-5. PubMed ID: 3194077 [No Abstract] [Full Text] [Related]
32. [Too complex for legislative regulation? Patient autonomy is a case for the family physician]. Thomas A MMW Fortschr Med; 2009 Apr; 151(16):8. PubMed ID: 19658285 [No Abstract] [Full Text] [Related]
33. Assessing health risks of complementary alternative medicines in cancer patients. Shia G; Shaw D; Dargan PI Br J Cancer; 2004 Aug; 91(5):995-6; author reply 996-7. PubMed ID: 15266321 [No Abstract] [Full Text] [Related]
34. Keeping up with alternative medicine: researchers offer evaluation criteria. Reynolds T J Natl Cancer Inst; 2003 Jan; 95(2):96-8. PubMed ID: 12529337 [No Abstract] [Full Text] [Related]
35. [Breaking bad news in oncology--more a matter of relation than information]. Salander P Lakartidningen; 2003 Feb; 100(7):510-2, 515-6. PubMed ID: 12640985 [TBL] [Abstract][Full Text] [Related]
36. Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Tully AA; Diaz GC; Renz JF AMA J Ethics; 2016 Feb; 18(2):101-7. PubMed ID: 26894805 [No Abstract] [Full Text] [Related]
37. Integrative therapies for children with hematological malignancies. Kelly KM Hematology Am Soc Hematol Educ Program; 2009; ():307-12. PubMed ID: 20008215 [TBL] [Abstract][Full Text] [Related]
38. [Cancer patients and information: another point of view of the question]. Fainzang S Bull Cancer; 2007 Mar; 94(3):313-5. PubMed ID: 17371774 [No Abstract] [Full Text] [Related]
39. [Communication between cancer patients and physicians regarding unconventional treatments]. Rønnov L; Langgaard H; Launsø L Ugeskr Laeger; 2005 May; 167(21):2285-9. PubMed ID: 15962857 [No Abstract] [Full Text] [Related]
40. The advance directive: an expression of autonomy, but also of care. Schaefer K; Eibach U; Roy D Ethics Med; 2002; 18(1):15-9. PubMed ID: 14700016 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]